Search Result "glatiramer acetate (GA)"
Demonstration of Biological and Immunological Equivalence of a Generic Glatiramer Acetate
Journal: CNS & Neurological Disorders - Drug Targets
Volume: 16 Issue: 6 Year: 2017 Page: 714-723
Author(s): Josephine D`Alessandro,Kevin Garofalo,Ganlin Zhao,Christopher Honan,Jay Duffner,Ishan Capila,Ian Fier,Ganesh Kaundinya,Daniel Kantor,Tanmoy Ganguly
Effect of Glatiramer Acetate on Peripheral Blood Brain-Derived Neurotrophic Factor and Phosphorylated TrkB Levels in Relapsing- Remitting Multiple Sclerosis
Journal: CNS & Neurological Disorders - Drug Targets
Volume: 13 Issue: 4 Year: 2014 Page: 647-651
Author(s): Vitalie Vacaras,Zsigmond Z. Major,Dafin F. Muresanu,Tibor L. Krausz,Ioan Marginean,Dana A. Buzoianu
A Comparative Study on Approval of Follow-on Version of SevelamerCarbonate and Glatiramer Acetate (GA) in US, EU
Journal: Applied Drug Research, Clinical Trials and Regulatory Affairs
Volume: 10 Issue: 1 Year: 2024 Page: 14-21
Author(s): Vikesh Kumar Shukla
Disease-Modifying Agents in the Treatment of Multiple Sclerosis: A Review of Long-Term Outcomes
Journal: CNS & Neurological Disorders - Drug Targets
Volume: 8 Issue: 6 Year: 2009 Page: 512-519
Author(s): Oleksandra Katrych, Tessa M. Simone, Shara Azad, Shaker A. Mousa
Multiple Sclerosis: Pathogenesis and Treatment
Journal: Current Neuropharmacology
Volume: 9 Issue: 3 Year: 2011 Page: 409-416
Author(s): Ingrid Loma, Rock Heyman
Pharmacogenomics of Multiple Sclerosis: Current Status and Potential Applications
Journal: Current Pharmacogenomics and Personalized Medicine
Volume: 8 Issue: 4 Year: 2010 Page: 273-279
Author(s): Masaaki Niino, Seiji Kikuchi
Advances in Therapies for Multiple Sclerosis
Ebook: Frontiers in Clinical Drug Research - CNS and Neurological Disorders
Volume: 1 Year: 2013
Author(s): Naila Makhani,Eluen A. Yeh
Doi: 10.2174/9781608057580113010004
Etiopathogenesis, Classical Immunotherapy and Innovative Nanotherapeutics for Inflammatory Neurological Disorders
Journal: Current Nanoscience
Volume: 7 Issue: 1 Year: 2011 Page: 2-20
Author(s): Maria Jose Sa, Joana Guimaraes, Pedro Abreu, Amelia Mendes, Eliana B. Souto
Disease Modifying Drugs in Multiple Sclerosis: Mechanisms of Action and New Drugs in the Horizon
Journal: CNS & Neurological Disorders - Drug Targets
Volume: 11 Issue: 5 Year: 2012 Page: 610-623
Author(s): Monica Marta,Gavin Giovannoni
The Effectiveness of Dimethyl Fumarate Monotherapy in the Treatment of Relapsing-Remitting Multiple Sclerosis: A Systematic Review and Meta-Analysis
Journal: Current Neuropharmacology
Volume: 12 Issue: 3 Year: 2014 Page: 256-268
Author(s): Pawel Kawalec,Alicja Mikrut,Natalia Wisniewska,Andrzej Pilc